Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Lawrence

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Thomas S Harrison, David S Lawrence, Henry C Mwandumba, et al.
The Journal of Biological Chemistry|July 31, 2003
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plagueFubo Liang, Zhonghui Huang, Seung-Yub Lee, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
BMJ Open|April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitisDavid S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2024
Photothrombolytics: A light-driven technology for the targeted lysis of thrombiBasanta Acharya, Caylie A McGlade, Haifeng Yin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV diseaseJayne Ellis, Laura Joan Nsangi, Mohammed Rassool, et al.
Biochemistry|November 5, 2003
Cellular effects of small molecule PTP1B inhibitors on insulin signalingLaiping Xie, Seung-Yub Lee, Jannik N Andersen, et al.
The Lancet. HIV|March 29, 2025
Causes of hospitalisation among people living with HIV worldwide, 2014-23: a systematic review and meta-analysisRachael M Burke, Nadia Sabet, Jayne Ellis, et al.
Journal of the American Chemical Society|February 21, 2015
B(12)-mediated, long wavelength photopolymerization of hydrogelsZachary L Rodgers, Robert M Hughes, Laura M Doherty, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2022
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in BotswanaNametso Kelentse, Sikhulile Moyo, Wonderful T Choga, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Thomas S Harrison, David S Lawrence, Henry C Mwandumba, et al.
The Journal of Biological Chemistry|July 31, 2003
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plagueFubo Liang, Zhonghui Huang, Seung-Yub Lee, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
BMJ Open|April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitisDavid S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2024
Photothrombolytics: A light-driven technology for the targeted lysis of thrombiBasanta Acharya, Caylie A McGlade, Haifeng Yin, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV diseaseJayne Ellis, Laura Joan Nsangi, Mohammed Rassool, et al.
Biochemistry|November 5, 2003
Cellular effects of small molecule PTP1B inhibitors on insulin signalingLaiping Xie, Seung-Yub Lee, Jannik N Andersen, et al.
The Lancet. HIV|March 29, 2025
Causes of hospitalisation among people living with HIV worldwide, 2014-23: a systematic review and meta-analysisRachael M Burke, Nadia Sabet, Jayne Ellis, et al.
Journal of the American Chemical Society|February 21, 2015
B(12)-mediated, long wavelength photopolymerization of hydrogelsZachary L Rodgers, Robert M Hughes, Laura M Doherty, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2022
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in BotswanaNametso Kelentse, Sikhulile Moyo, Wonderful T Choga, et al.
Pageof 16